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Background: Controversial results have been reported regarding plasma adiponectin levels in preeclampsia
(PE) compared to healthy pregnancies (HP). Adiponectin activates eNOS, increasing the levels of the vasodilator
nitric oxide (NO). PE reduces the levels of nitrite (an NOmarker) and induces higher levels of ADMA (an endog-
enous eNOS inhibitor) compared to HP. No previous study has examined whether a positive correlation exists
between adiponectin and nitrite in HP and PE and how ADMA may interfere with this correlation.
Methods: We measured plasma nitrite concentrations using an ozone-based chemiluminescence assay, and
plasma ADMA and adiponectin levels using enzyme immunoassays in 117 pregnant women (70 healthy and
47 preeclamptic).
Results: We found higher adiponectin levels (23.6 ± 13.0 vs. 17.8 ± 5.6 µg/ml; P b 0.05) and lower plasma
nitrite levels (104.5 ± 84.3 vs. 177.2 ± 151.3 nM; P b 0.05) in PE compared to HP.We found a signiﬁcant positive
correlation between thesemarkers inHP (r = 0.3; P b 0.05), but no correlation in PE. However, whenwe grouped
PE women regarding ADMA levels (low and high levels), a strong positive correlation was found in the group
with lower ADMA levels (r = 0.67; P b 0.05), suggesting that high ADMA concentrations may interfere with
the physiological activation of eNOS by adiponectin in PE.
Conclusions: Our ﬁndings showed higher levels of adiponectin and lower nitrite levels in PE compared to HP, and
these levels were positively correlated in HP and in PE presenting lower concentrations of ADMA.© 2013 Elsevier B.V. All rights reserved.1. Introduction
Preeclampsia (PE) is a syndrome of pregnancy characterized by
hypertension and proteinuria after 20 weeks of gestation which affects
3–5% of all pregnancies. The development of PE results in maternal and
fetal complications, including renal failure, cerebral edema, liver failure,
low birth weight, prematurity, and death [1]. Although the pathophys-
iology of preeclampsia is not completely understood, several lines of
evidence point to a failure of cytotrophoblast invasion and the absence
of dilatation of uterine arteries leading to a high-resistance uteroplacental
circulation, thus decreasing placental perfusion and causing hypoxia,
which in turn induces the release of factors causing systemic endothelial
dysfunction into the maternal circulation [2].
Some authors have suggested the involvement of adiponectin in PE
pathology due to its participation in endothelial nitric oxide synthase
(eNOS) activation and consequently in nitric oxide (NO) synthesis,e Pesquisa, Santa Casa de Belo
azil. Tel./fax:+55 31 3238 8838.
drim).
rights reserved.which plays an essential role in the reduction of blood pressure during
healthy pregnancy [3]. Additionally, lower NO bioavailability has been
observed in preeclamptic women compared to healthy pregnant
women [4]. Abnormal circulating adiponectin levels have been detected
in many cardiovascular conditions [5–7], including PE [8,9]. However,
the results are controversial, with some studies demonstrating higher
levels of adiponectin in PE compared to healthy pregnant (HP) women
[8,10], and others showing decreased levels in PE women [11,12].
In the present study, we compared the circulating adiponectin con-
centrations in healthy pregnant women to those found in preeclamptic
women. Moreover, based on the fact that adiponectin activates endoge-
nous NO formation, we hypothesized that nitrite levels are positively
associated with plasma adiponectin concentrations in pregnant women.
2. Materials and methods
2.1. Subjects
Approval for use of human subjects was obtained from the Insti-
tutional Review Board at the Faculty of Medicine of Ribeirao Preto,
Table 1
Demographic characteristics of study participants.
Parameters Healthy pregnancy Preeclampsia
n 70 47
Age (y) 25.1 ± 5.8 27.1 ± 7.7
Primigravida (%) 44.3 42.5
SBP (mm Hg) 114.5 ± 10.1 143.3 ± 16.7⁎
DBP (mm Hg) 74.0 ± 8.5 89.5 ± 14.1⁎
GA sampling 36.8 ± 2.6 34.2 ± 4.0⁎
GAD (weeks) 39.7 ± 1.4 35.7 ± 3.7⁎
Pre-pregnancy BMI (kg/m2) 22.8 ± 3.3 23.8 ± 4.0
Newborn weight (g) 3341.0 ± 596.0 2411.2 ± 889.7⁎
IUGR (%) 6.1 28.2
24-h-Pr (mg/24 h) ND 1418.7 ± 1379.4
Creatinine (mg/dl) ND 0.68 ± 0.14
Plasma nitrite (nM) 177.2 ± 151.3 104.5 ± 84.3⁎
Adiponectin (µg/ml) 17.8 ± 5.6 23.6 ± 13.0⁎
SBP, systolic blood pressure; DBP, diastolic blood pressure; GA, gestational age; GAD,
gestational age at delivery; BMI, body mass index; IUGR, intrauterine growth restriction;
24-h–Pr, 24-h proteinuria; ND: not determined. Values are the mean ± S.D.
⁎ P b 0.05 vs. healthy pregnant group.
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from all participants. A total of 117 pregnant women were enrolled
in the Department of Obstetrics and Gynecology, University Hospital
of the Faculty of Medicine of Ribeirao Preto. Of these, 70 were HP
women with uncomplicated pregnancies and 47 had PE. Hypertensive
disorders were deﬁned according to the guidelines of the National High
Blood Pressure Education Program Working Group on High Blood
Pressure in Pregnancy (NHBPEP) [13].
Preeclampsiawas deﬁned as increased blood pressure (≥140 mm Hg
systolic or ≥90 mm Hg diastolic on the occasion of 2 or more measure-
ments at least 6 h apart) with signiﬁcant proteinuria (≥0.3 g/24 h) in
a woman after 20 weeks of gestation. No women with pre-existing
hypertension, with or without superimposed PE, were included in the
present study. Exclusion criteria were: twin or multiple pregnancies,
pre-pregnancy body mass index (BMI) over 30 kg/m2 or any evidence
of previous medical diseases. Intrauterine growth restriction (IUGR)
was considered to be present if the infant birth weight was the below
the 10th percentile of a normal reference curve reported for the Brazilian
population [14].
At the time of clinic attendance, maternal venous blood samples
were collected into standard Vacutainer tubes (Becton–Dickinson)
containing heparin (to measure plasma nitrite concentrations) and
EDTA (to measure plasma ADMA and adiponectin concentrations).
The tubes were immediately centrifuged at room temperature and
plasma samples were stored at −70 ºC until the time for biomarker
measurements.
2.2. Assessment of biomarkers
Plasma concentrations of ADMA were measured with commer-
cially available enzyme-linked immunosorbent assay (ELISA) kits (DLD
Diagnostika GmbH, Hamburg, Germany) according to manufacturer's
instructions. Plasma adiponectin concentrations were measured using
commercially available ELISA kits (Human Adiponectin EZHADP-61K —
Millipore, St. Charles, MO), according to themanufacturer's instructions.
Nitrite concentration was measured by injecting 200 μl of plasma
samples into a solution of acidiﬁed triiodide and purging with
nitrogen in-line with a gas-phase chemiluminescence NO analyzer
(SieversModel 280NOAnalyzer). Approximately 8 ml of triiodide solu-
tion (2.0 g of potassium iodide and 1.3 g of iodine dissolved in 40 ml of
water with 140 ml of acetic acid) were placed in the purge vessel into
which plasma samples were injected. The triiodide solution reduced
nitrites to NO gas, which was detected by the NO analyzer [4].
2.3. Statistical analysis
Clinical features and biomarker data are reported as mean ± SD.
The groups assessed were compared by the Student t-test. Biomarkers
were correlated by the Pearson test. The level of signiﬁcance was set
at P b 0.05.
3. Results
Clinical data were collected from the HP and PE groups (Table 1).
We found no statistically signiﬁcant differences in age, % primigravida
or BMI between groups PE (all P > 0.05). However, PE women had
a signiﬁcantly higher percentage of IUGR and higher systolic and
diastolic blood pressure levels than HP. Lower birth weights and ges-
tational ages at delivery were found in PE compared to HP. Although a
signiﬁcant difference was found regarding gestational age sampling,
none of the parameters measured was inﬂuenced by this variation.
As previously reported [4], plasma nitrite levels were signiﬁcantly
reduced in PE compared to HP, while plasma adiponectin levels
were 32.6% higher in PE compared to HP (P b 0.05; Table 1). In
addition, we performed correlation analysis between adiponectinand BMI and found a negative correlation in the HP group (r = −0.40;
P = 0.001), but not in the PE group (r = −0.08; P = 0.61).
To determine whether any association existed between the circu-
lating adiponectin and nitrite levels (NO marker); we performed
correlation analysis separately in HP and PE women. We observed a
signiﬁcant positive correlation between adiponectin and nitrite levels
only in the HP group (r = 0.3; P = 0.02; Fig. 1A), but not in the
PE group (r = 0.12; P = 0.42; Fig. 1B). Since adiponectin activates
eNOS, we assume that the endogenous eNOS inhibitor (ADMA), which
is elevated in PE [15], may interfere with a possible correlation between
adiponectin and nitrite levels in the PE group. Thus, we measured
ADMA in a set of PEwomen (n = 34) and sub-grouped those presenting
the 50% lowest (L group, n = 17) and 50% highest (H group, n = 17)
ADMA levels. Next, we calculated the correlation between nitrite
and adiponectin in each group. Interestingly, we found a positive correla-
tion between adiponectin and nitrite levels in the L group (r = 0.67;
P = 0.006, Fig. 1C), whereas no correlation was detected n the H group
(r = −0.22, P = 0.39, Fig. 1D).
4. Discussion
This is the ﬁrst study to demonstrate a positive association between
circulating adiponectin concentrations and nitrite levels in HP. More-
over, we observed increased levels of adiponectin in PE compared to
HP, and reduced nitrite levels in the PE group.
Several studies have measured adiponectin levels in PE expecting
reduced values compared to HP since this molecule activates eNOS.
However, literature ﬁndings are controversial [8,10–12] moreover,
no study was performed in the Brazilian population. Ramsay et al.
[8] were the ﬁrst to demonstrate high levels of adiponectin in PE,
and they suggested that this increase was due to the increased release
mediated by excessive lipolysis in adipocytes or a physiological re-
sponse to minimize the excess accumulated fat tissue in PE. However,
other authors [16] have suggested that elevated adiponectin levels
may represent a response caused by an imbalance of angiogenic
factors derived from the placenta in patients with PE. On the other
hand, Sullivan et al. [17] suggested that the higher levels of adiponectin
do not indicate an important link between PE and endothelial dysfunc-
tion, suggesting the study of adiponectin isoforms to amplify our knowl-
edge. However, studies addressing the evaluation of adiponectin isoforms
are also controversial [18,19].
Besides the importance of comparing the adiponectin levels be-
tween the HP and PE groups, our results also reﬂect a biological effect
on endothelial function. Therefore, the current study aimed to evalu-
ate this process through the correlation of adiponectin concentration
with plasma levels of nitrite, and we found a contribution of NO
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Fig. 1. Correlation between plasma adiponectin and nitrite levels in healthy pregnant women (A), all preeclampsia pregnant women (B),and in pregnant women with preeclampsia
according to the lowest (L group, C) and highest (H group, D) ADMA levels.
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is characterized by increased body weight including fat deposits and
consequently elevations in the concentrations of adipokines [20], in
particular adiponectin. The latter, in turn, through interaction with
speciﬁc receptors promotes activation of eNOS and thus of NO. Plasma
nitrite levels represent approximately 70% of eNOS [21], and inhibition
of NO synthase activity was associated with corresponding decreases
in circulating nitrite concentrations [22]. We observed a signiﬁcant
decrease of nitrite levels in PE compared to HP, supporting previous
ﬁndings [4]. Interestingly, when we sub-grouped PE women into
subjects with lower or higher levels of ADMA, the endogenous NOS
inhibitor, we found a positive correlation between adiponectin and
nitrite, suggesting that higher ADMA concentrations may interfere
with the physiological activation of eNOS by adiponectin. The biological
mechanism behind this ﬁnding is still unknown, limiting an in-depth
discussion of our work. However, these results can direct other clinical
and basic studies, besides demonstrating once again the importance of
ADMA in the physiology of PE, as reported in several studies [15,23–26].
In conclusion, our ﬁndings show higher levels of adiponectin and
lower nitrite levels in PE compared to HP, and these levels are posi-
tively correlated in HP and in PE presenting lower concentration of
ADMA. Furthermore, these results have important implications for
future studies on adiponectin, NO and ADMA biology and therapeutic
perspectives for PE.
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